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Pharmacist’s contribution to the promotion of access 
and rational use of essential medicines in SUS
Abstract  Objective: to describe the pharma-
ceutical inclusion process in a Basic Health Unit 
multidisciplinary team and evaluate results relat-
ed to rational use and promotion of access to es-
sential medicines. Methods: This is a descriptive, 
cross-sectional study conducted in a primary care 
health unit in the city of São Paulo. Pharmacist’s 
activities were evaluated regarding the service 
structure and organization and prescribing qual-
ity improvement, guidance method creation, and 
implementation of clinical pharmacy service. 
Data measured before and after the interventions 
and between 2010 and 2011 were analyzed using 
Pearson´s chi-square test with a significance level 
of 5%, and odds ratio. Results: Pharmacist’s ac-
tivities had statistically significant result in drug 
shortage reduction; prescribing quality improve-
ment associated with an increased proportion of 
prescriptions met; decrease in the total of pre-
scribed drugs among patients receiving pharma-
cotherapeutic follow-up and, comparing the years 
2010 and 2011, changes in the pharmacotherapy 
recommendations have gained increased accep-
tance level. Conclusions: Pharmacist’s activities 
may effectively provide rational use and promo-
tion of access to essential medicines.
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Introduction
Several studies have shown that the insertion of 
the pharmacist in the multidisciplinary team re-
sults in more cost-effective outcomes, but most 
of these studies were directed to the study of spe-
cific public, disease or situation1-7.
A recently published systematic review has 
observed that most studies related to the provi-
sion of pharmaceutical services in primary care 
were conducted in the United States, United 
Kingdom and Canada, respectively8. Considering 
only the studies in which the pharmacist worked 
in the same unit as the general practitioner, in or-
der to evaluate the impact of the insertion of this 
professional in the team and their interventions, 
most of the studies (25/38) were found to report 
positive effects in at least one aspect of care. More 
expressive results were achieved when the phar-
macist interacted with the prescriber personally, 
reinforcing the observation that the presence of 
the pharmacist in the primary care services is 
essential to ensure effective communication and 
the establishment of interpersonal relationships 
in order to increase the probability of success in 
the interventions8. 
Brazil’s progress in public health policies and 
the promotion of access to essential medicines 
since the National Drug Policy (PNM) in 1998 is 
indisputable. Studies evaluating the federal gov-
ernment’s pharmaceutical care programs have 
shown a significant increase in supply of medi-
cines through these programs as well as the fact 
that public procurement has become more effi-
cient9-11.
Although the programs for free distribution 
of medicines in SUS were initiated shortly after 
the publication of the PNM, pharmaceutical care 
on a systemic basis beyond the logistics aspect to 
include service delivery has only been prioritized 
more recently. In particular, for the increased sup-
ply of training in pharmaceutical and manage-
ment services and funding line for this purpose. 
Despite these efforts, according to a study carried 
out by the Ministry of Health in partnership with 
the Pan American Health Organization (PAHO), 
the availability of the main medicines in inventory 
was 73% in health units. As for prescribed medi-
cines, the proportion dispensed or administered 
at health facilities was 66%, which suggests lack of 
medication or compliance to selected medicines12.
The number of pharmacists in the Unified 
Health System (SUS) is recent and still insuffi-
cient, especially in the dispensation of medicines 
in the UBS. According to data from the Region-
al Pharmacy Council of the State of São Paulo 
(CRF-SP), 2346 (73%) of the 3214 public phar-
macies in the municipalities of the State of São 
Paulo had no pharmacist13. There is no available 
literature that identifies how many pharmacies of 
the Basic Health Unit (UBS) have a pharmacist 
in Brazil, but a study carried out by the Nation-
al Agency of Sanitary Surveillance (ANVISA) in 
2009 to evaluate the influence of the pharmaceu-
tical industry on SUS, identified lack of pharma-
cists in 7 out of 10 SUS pharmacies14.
The basic elements of primary care and phar-
maceutical services are the same and include 
centrality of patient care, treatment of acute and 
chronic disorders, emphasis on the prevention of 
diseases; documentation of the service provid-
ed, access, continuous and systematic care, inte-
gral care, responsibility for treatment, training/
promotion of education and health15. Although 
the clinical impact of the pharmacist has already 
been studied, there is a shortage of studies that 
demonstrate improved access to medication, pre-
scription quality and promotion of rational use 
of medicines after insertion in primary health 
care teams, especially when this professional ac-
cumulates administrative functions. The objec-
tive of this work is to describe and evaluate the 
results of the insertion of a pharmacist in the 
multiprofessional team of a basic health unit re-
garding the promotion of access and rational use 
of essential medicines.
Material and methods
The work was carried out in a health unit of 
the Municipal Health Department of São Pau-
lo, which is under the management contract of 
a social organization (Western Region Project, 
School of Medicine of USP). This unit includes a 
Medical Ambulatory Care Service (AMA), a Ba-
sic Health Unit (UBS) with four Family Health 
Strategy (ESF) teams, comprising 42,479 inhabi-
tants in its area of coverage.
With the hiring of the pharmacist, in May 
2007, a series of actions were initiated whose re-
sults will be presented considering different as-
pects of the pharmacist’s performance: 
a) Structuring and organization of the service; 
b) Study and interventions to improve the medi-
cation prescription standard; c) Elaboration and 
adoption of a method for standardized guidance 
for patients with polypharmacy or difficulties in 
complying with the prescribed dosing schedule; d) 
Clinical Pharmaceutical Services.
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The structure and organization of the service 
comprised all activities related to the implementa-
tion of physical space improvements and manage-
rial processes, such as changing the pharmacy lo-
cation – both dispensing and inventory; daily and 
weekly inventories, according to the characteris-
tics of the medicines; exchange of medications 
among units to reduce drug loss due to expiration; 
and the training of the staff - initially composed 
of nursing assistants who were gradually replaced 
by four pharmacy technicians - through biweekly 
meetings with a maximum duration of 30 min-
utes, which included a class of about 10 minutes 
and discussion. In this work, a professional with 
full technical course or at least two years of experi-
ence in drug dispensing was considered as a phar-
macy technician. There were the requirements 
applied in the job selection process.
The study and interventions to improve the 
medicine prescription standard occurred in two 
stages: the intervention priorities were listed (for 
intervention and also for staff training) and phar-
maceutical interventions were initiated. In order 
to list the pharmacist’s intervention priorities, 
the prescriptions presented to the pharmacy ser-
vice were studied to identify the main problems 
that had an impact on access to medicines. In 
June and July 2007, data were manually collect-
ed in standard form, referring to 1,200 prescrip-
tions. At the time of medicine dispensing, previ-
ously trained pharmacy technicians recorded the 
prescribing data (source, number of prescription 
items, medicines prescribed by the generic name 
of the drug, prescribed medicines belonging to 
the Municipal List of Essential Medicines – RE-
MUME – and number of medicines dispensed).
After the problems were listed, the pharma-
ceutical interventions to be performed were de-
fined in meetings with all members of the phar-
macy team. After the first year of work and greater 
integration into the team, these discussions start-
ed to involve the other professionals of the health 
team – nurses, physicians, administrative recep-
tion technicians, social worker and manager.
The results were compared using data from 
the pharmacy, collected in a standard form, in an 
Excel® worksheet. Data from 16,720 medical pre-
scriptions were evaluated between July and Octo-
ber 2011. The average data recording rate in the 
data collection worksheet was 90% – comparing 
data from the spreadsheet and the computerized 
inventory control system, which was considered 
representative for all pharmacy services. Statisti-
cal analysis was performed using Pearson’s chi-
square test, with significance level of 5%. Addi-
tionally, to evaluate the association between the 
result and the intervention, ODDs Ratio was cal-
culated using Epi Info® program.
From the observation that a) there were 
medicines whose packaging was very similar, 
and could confuse the patients; b) some of the 
patients treated were illiterate and needed in-
dividualized guidance to follow the prescribed 
dosing schedule; c) there was not enough time to 
make boxes for patient orientation; alternatives 
were discussed to standardize the form of indi-
vidualized orientation. Therefore, a standardized 
method was elaborated using a color chart and 
printed in calendar form, containing pictograms 
representing periods of the day, such as morning, 
lunch and night, or actions, such as getting up or 
going to sleep.
Although the pharmacist started assisting 
patients in consultation from his hiring, when 
necessary, the registration of these activities was 
only performed from the end of 2009. Thus, the 
results will be presented for the years 2010 and 
2011, when the staff was already qualified, phar-
macy service structured and pharmacists could 
dedicate themselves almost exclusively to the 
clinical pharmaceutical services, emphasizing the 
realization of groups of health education, phar-
maceutical care and the pharmacotherapeutic 
follow-up, when necessary. Acceptance of the 
pharmacist’s recommendation and mean num-
ber of prescribed medications were compared 
using Pearson’s chi-square test, at a significance 
level of 95%, using Epi Info® program. Adapted 
Dader method16 was used in the pharmacothera-
peutic follow-up.
As data for research were obtained from pre-
scriptions and administrative records, the work 
was exempted from mandatory approval by the 
Ethics Committee, although the recommenda-
tions of CNS Resolution 466/2012 were followed.
Results
Structuring and organization of the service
In the first inventory of medicine stocks 
(05/28/2007), 168 (93%) of the evaluated medi-
cine presented a discrepancy between the amount 
discriminated in the computerized system and 
that observed in the physical stock. In the second 
inventory (04/06/2007), the number was only 87 
(48%). In the inventories carried out from Jan-
uary to October 2012, the average number of 
drugs with a discrepancy was only 4%. As a result 
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of stock management, non-dispensing of RE-
MUME prescription drugs in the unit, due to the 
lack, was reduced from 10.7% (in 2007) to 1.3% 
(in 2011), p < 0.0000001. In 2010, this pharmacy 
became the reference service for the dispensing 
of tuberculostatics and oseltamivir to the Pro-
visional Detention Centers and the hospitals of 
the region for being considered well organized. 
Also in that year, the pharmacist became part 
of the continuing education team in the region, 
participating and coordinating training courses 
for pharmacists and technicians of the munici-
pal network and receiving residents of pharmacy 
from a program of the School of Pharmaceutical 
Sciences of the University of São Paulo, in 2012.
Study and interventions to improve 
the medication prescription standard
Concomitant to the process of service struc-
turing, situations that could require interventions 
by the pharmacist were surveyed, with particu-
lar attention to access to medicines. In the 1200 
consultations evaluated between June and July 
2007, prescription presented was fully met in 820 
(68.3%) of them, meaning that all the prescribed 
medicines were dispensed; In 329 (27.4%) the 
prescription was partially met. In the 51 consul-
tations where no medication was dispensed, the 
cause was technical or legal irregularities of the 
prescription.
In the initial period, 2007, 2,642 medica-
tions were prescribed, considering those pres-
ent in the fully or partially met prescriptions. 
Of these, 1,288 (48.8%) were prescribed using 
the commercial name of the drug. In addition, 
of these 2,642 medicines, 521 (19.7%) were not 
part of the municipal list of essential medicines 
(REMUME). Of the 2,121 drugs prescribed and 
standardized in REMUME, 418 (15.8%) were not 
dispensed: 282 (10.7%) were missing and 136 
(6.4%) were due to reasons related to the dosage 
regimen or illegibility.
The problems listed and the interventions 
adopted are described in Table 1. Table 2 shows 
the results of the pharmacist’s performance to 
promote the improvement of the medication 
prescription standard, comparing data from 
the initial period (June and July 2007) and the 
post-intervention period (July to October 2011).
Elaboration of a method for individualized 
and standardized guidance for patients with 
polypharmacy or difficulties in complying 
with the prescribed dosing schedule 
The method adopted to guide patients with 
difficulties to follow the prescribed dosing reg-
imen was elaborated and improved over three 
years. The guideline includes pictograms and a 
standardized color chart to allow the technician 
to identify potentially harmful interactions (eg 
amiodarone, simvastatin and digoxin were iden-
tified with the same color so that when used con-
comitantly, would alert the need for the pharma-
cist to be advised to assess the benefit-risk of the 
combination).
During 2011, 712 patients were instruct-
ed by pharmacy technicians using this method, 
581 (82%) of whom returned to get their med-
ications in the following months and to comply 
with the dosing regimen according to the medical 
prescription, according to the patient’s report. In 
131 (18%), the technician’s orientation did not 
allow the understanding of the dosing schedule 
and the patients were referred to the pharmacist.
Clinical Pharmaceutical Services
Table 3 describes the clinical pharmaceutical 
services performed during the years 2010 and 
2011.
The topics addressed in the health education 
groups in 2010 were on the need for the continu-
ous use of medications by diabetic and hyperten-
sive patients; And in 2011, on topics related to the 
treatment of hypertension and diabetes (diet and 
medication use), risks of self-medication, med-
ication storage and self-medication of children 
(the latter being taught at a school in the region, 
at the parents’ meeting, at the request of school 
board). From 2011 onwards, in addition to pro-
moting health education groups, the pharmacist 
started participating in the multidisciplinary 
group of tobacco control in the unit.
The reasons for the pharmaceutical care in 
the two years of the study were: obtaining in-
formation on access to medicines in SUS, 238 
(25.2%); need for medication conciliation, 224 
(23.7%); complex therapeutic regimen (ie, 5 or 
more medicines prescribed), 108 (11.4%); recent 
changes in pharmacotherapy (inclusion, exclusion 
or replacement of medications), 98 (10.4%); clar-
ification of doubts about medicines, 89 (9.4%); 
suspected adverse drug reaction, 82 (8.7%); non 
compliance with pharmacological therapy, 67 
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(7.1%); and suspected therapeutic ineffective-
ness, 39 (4.1%).
Although most of the pharmaceutical care 
was performed due to the identification of prob-
Chart 1. Problems identified in prescriptions evaluated between June and July 2007 and interventions in a basic 
health unit of São Paulo.
Problem Interventions
1. Technical or legal irregularities 
of prescription
. Educational intervention with the unit prescribers through face-to-
face interventions;
. Development of internal memos (signed by the pharmacist and the 
manager), given the difficulty in gathering prescribers for discussion 
and guidance.
. During an adjustment period of six months, the pharmacy team 
sought the physician requesting the correction of errors in prescribing. 
A month before the end of this period, in April 2010, a new internal 
memo reinforcing the information was developed;
. Internal campaigns on topics relevant to patient safety as 
identification of the medication, legibility of the prescription, properly 
described dosage regimen etc.
2. Medicines prescribed using the 
trade name of the drug
3. Expiration of drug 
prescriptions for treatment of 
chronic conditions
. Implemented the use of a stamp with fields for the six months of care 
prescription, allowing easy viewing patient how many blank fields (ie 
months of validity of the prescription) still remaining after the current 
service;
. Partnership with the reception staff for scheduling patients when 
requested by the pharmacy.
4. Drugs not in REMUME . Dissemination of REMUME and CEAF drug list, through a periodical 
publication;
. Face-to-face interventions with the prescriber to recommend 
alternative available therapies.
5. Lack of medicines contained in 
REMUME
. Stock management optimization with periodic inventories; drug 
exchanges among units to avoid overdue losses; etc
Table 1. Results of interventions performed to improve the standard of medical prescription in a basic health 
unit in São Paulo, comparing the previous period (June to July 2007) and subsequent (July to October 2011) 
with the inclusion of the pharmacist.
Before After p
Odds ratio
(IC 95%)
Prescriptions fully met 68.3%
(820/ 1.200)
87.3% 
(14,597/16,720)
< 0.0000001 3.19
(2.80 - 3.63)
Prescriptions not met due to technical 
or legal irregularities
4.2%
(51/1.200)
1.8%
(301/16,720)
< 0.0000001 0.41
(0.30 - 0.56)
Prescribed medicines not included 
in REMUME
19.7%
(521/2,642)
4.2%
(1,545/36,792)
< 0.0000001 0.18
(0.16 - 0.20)
Prescribed medicines employing 
the generic name of the drug
51.2%
(1,354/2,642)
94.4% 
(34,732/36,792)
< 0.0000001 16.04
(14.68 – 17.52)
Prescribed medicines (from REMUME) 
missing
10.7%
(282/ 2,121)
1.3%
(458/35,247)
< 0.0000001 0.08
(0.07 - 0.10)
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lems by pharmacy technicians or the pharmacist 
during the dispensing of medicines (846; 89.5%), 
some of the patients were referred by the unit’s 
physicians: 41 (11.0 %) in 2010 and 83 (14.5%) 
in 2011 - with a significant increase (p < 0.0001).
The reasons for the referral of patients to 
pharmaceutical care, considering 2010 and 
2011, were: recent changes in pharmacotherapy 
(68; 54.8%), complex therapeutic regimen (47; 
37.9%) and suspected therapeutic ineffectiveness 
(9; 7.3%). In addition, the physicians at the unit 
requested to discuss issues related to the phar-
macotherapy of patients on 28 occasions in 2010 
and 61 times in 2011.
Of the 945 patients assisted by the pharma-
cist, pharmacotherapeutic follow-up was initi-
ated for 105 (11.1%) - all of these patients were 
adherent to pharmacological treatment. How-
ever, only 64 (61.0%) continued the follow-up 
until the release (discharge) by the pharmacist. 
For these patients, average number of prescribed 
drugs was reduced from 7.4 ± 2.3 to 5.9 ± 1.7, p 
< 0.0001.
As a result of pharmaceutical care and phar-
macotherapeutic follow-up, 972 recommenda-
tions were made for changes in pharmacotherapy 
to prescribers, of which 659 (67.8%) were accept-
ed. As can be seen in Table 4, in which the num-
ber, type and acceptance or not of the recom-
mendations of the pharmacist to the prescriber 
are described, recommendations made through 
face-to-face intervention were better accepted 
than those that used medical records and/or note 
(p < 0.0001). There is also an increase in the ac-
ceptance of recommendations between 2010 and 
2011 (p < 0.0001).
In 2014, the report of these actions was recog-
nized with Honorable Mention in the Incentive 
Award in Science and Technology for the SUS.
Discussion
A study carried out in 2005 evaluating pharma-
ceutical services in Brazil observed that only 32% 
of the health units evaluated had stock records12. 
Table 2. Clinical pharmaceutical services performed between January 2010 and December 2011 in a basic health 
unit in São Paulo.
2010 2011 Total
Health Education Groups
Number of events 04 10 14
Number of participants (total) 64 259 323
Pharmaceutical services
Number of visits 374 571 945
Pharmacotherapeutic follow-up
Number of patients who started Pharmacotherapeutic 
follow-up 38 67 105
Table 3. Description of the type and acceptance of recommendations for changes in pharmacotherapy made by 
the pharmacist to the prescriber in a basic health unit of São Paulo between January 2010 and December 2011.
2010 2011 Total
Recommendations to the prescriber
Face-to-face 228 (59.1%) 390 (66.6%) 618 (63.6%)
Annotation in medical records and/or note 158 (40.9%) 196 (33.4%) 354 (36.4%)
Total 386 (100.0%) 586 (100.0%) 972 (100.0%)
Recommendations to the prescriber accepted
Face-to-face 158 (69.3%) 313 (80.2%) 471 (76.2%)
Annotation in medical records and/or note 74 (46.8%) 114 (58.2%) 188 (53.1%)
Total 232 (60.1%) 427 (72.9%) 659 (67.8%)
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In 2008, Vieira noted that, in municipalities with 
lack of medication, the most frequent problem 
(81%) was “absent or poor stock control”, based 
on municipal control reports from the Federal 
Comptroller’s Office (CGU) generated between 
August 2004 and July 200617. The provision of 
computerized systems promotes the qualification 
of medicine programming process, but loses its 
function when the registration of the informa-
tion is not reliable. Considering the large number 
of health units in the city of São Paulo, about six 
hundred, the purchasing schedule is very com-
plex and the reliability of the system information 
becomes essential to ensure adequate planning.
Regarding the lack of medicines, there are 
two aspects to consider. The first would be proper 
management of the stock of medicines. It results 
in reduction of waste and allows adequate pro-
gramming for the distribution of the drug from 
the warehouse to the unit. On the other hand, 
it is important to point out that there were also 
advances in medication management in the mu-
nicipal health department, with a direct impact 
on the observed results, such as the increase in 
the supply of computers and the implementation 
of the computerized system in all health units, as 
well as inclusion of new medicines in REMUME.
No other studies were found to report in-
creased access to medications following phar-
macist interventions for data comparison or a 
change in prescribing standard in primary care 
units. However, all parameters evaluated in re-
lation to the improvement of the prescription 
quality or increased access to the drugs were sta-
tistically significant and with a strong association 
with the intervention. It reinforces the finding of 
other authors that the presence of pharmacist in 
the primary health care service so that an inter-
personal relationship with the team and the pa-
tient can be established assures better results8.
Among the reasons for not dispensing pre-
scribed drugs were technical or legal irregularities 
in prescriptions, regardless of the origin of the 
prescription. In Brazil, millions of prescriptions 
generated annually in public health services do 
not meet the necessary technical and legal require-
ments for efficient dispensing and correct use of 
medicines18,19. The Brazilian average for complete 
prescriptions is 46%, with a significant variation 
among the evaluated states: 1.1% in Goiás, 27.2% 
in Pará, 29.3% in Rio Grande do Sul, reaching 
81.9% in Sergipe and 98.6% in Espírito Santo20. 
This scenario reflects the fact that the prescription 
is still not seen as a patient guidance document, 
but rather as a necessary formality for access21.
Prescriptions that did not contain all the nec-
essary information to ensure proper use of the 
drug (concentration, dosage schedule and treat-
ment time) were no longer met. Since it is com-
mon that there is only one concentration of the 
drug in the list of essential medicines, prescribers 
reported that they did not understand the need 
to describe it in the prescription.
Incomplete or illegible prescriptions associat-
ed with the low socioeconomic and cultural level 
of Brazilian patients are relevant factors in expos-
ing the various layers that make up the society, 
especially the elderly and children, to the possible 
problems related to medicines22. These problems 
feed back the demand for clinical services, often 
at more complex levels, reducing the cost/effec-
tiveness of treatments, unnecessarily burdening 
health expenses and decreasing patients’ quality 
of life23.
In order to reduce the prescription of over-
due continuous medications, the commitment 
of the pharmacy team as administrative techni-
cians responsible for scheduling, social workers, 
nurses and prescribers was essential. An increase 
in the number of physicians due to the implan-
tation of four ESF teams was also essential in 
2011. The greatest difficulty was the divergence 
in the rules of dispensing and validity of pre-
scription among the various health services and 
programs, generating problems for both patients 
and health professionals and managers (depend-
ing on the health service, the prescription is valid 
for 3 months (Farmácia Dose Certa), 4 months 
(Farmácia Popular), 6 months (UBS) or up to 
one year (Hospital das Clínicas de São Paulo, for 
example).
According to a study performed by Dal Piz-
zol et al.24, the availability of essential medicines 
in eight primary or secondary care services of 
municipalities in the central-southern region of 
the country was on average 88.1%, varying from 
53% to 93%. Emmerick et al.20, in a study car-
ried out in 5 Brazilian states, reported that the 
national average for the percentage of prescribed 
drugs dispensed or administered was 67.9%, 
varying from 89.6% in Espírito Santo to 52.6% 
in Rio Grande do Sul, considering the state and 
from 22.0% to 93.2% considering health units 
analyzed. Other authors report values varying 
from 60.3% to 80.7% of the prescribed drugs 
being met19,25-27 and describe problems to calcu-
late the indicator due to lack of dispensing an-
notation when supply occurs, different patterns 
of annotation between employees, dispensing of 
non-standard medicines due to free samples or 
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donations or not yet retaining the second way 
of prescription, compromising data collection. 
Since data collection was performed at the time 
of dispensing, not depending on retention of the 
second way or annotation, the problems reported 
in the calculation of the indicator were avoided. 
In addition, donations of medications and free 
samples were not accepted as the source and 
quality of the product could not be assured.
According to Emmerick et al.20, the national 
average number of prescriptions using the gener-
ic name was 84.2%, ranging from 80.6% in Pará 
to 92.7% in Espírito Santo. Prescription through 
the generic name is an essential factor in promot-
ing the rational use of medicines as it favors the 
identification of the drug by the patients. In addi-
tion, it facilitates the process of health education 
performed at the time of dispensing the drug.
Brazilian studies have already described the 
difficulty of many patients in understanding the 
prescribed regimen28-32. The understanding of 
prescription varied in studies conducted in other 
cities, and according to the methodology, ranging 
from 34% to 70%25,26,31. However, a visual iden-
tification system with the use of standardized 
colors and print-outs allowed the majority of pa-
tients to adequately comply with the medication 
prescription – according to the patients’ reports 
– without the need for direct action of the phar-
macist. It shows the relevance of the guidance 
given by pharmacy technicians since it would 
be impracticable for the pharmacist to assist all 
patients. In fact, the training of technicians and 
the systematization of medicine dispensation, 
in order to contribute to the identification, and 
even to the resolution, of some problems relat-
ed to the use of medicines or the quality of the 
prescription allowed to optimize the time of the 
pharmacist. Thus, he/she can be more involved in 
clinical activities, which has already been report-
ed in international studies33-36.
All aspects evaluated in relation to clinical 
pharmaceutical services and integration with 
the multidisciplinary team showed improvement 
when compared to 2010 and 2011. It includes the 
acceptance of the recommendations of the phar-
macist to the prescriber for changes in patients’ 
pharmacotherapy. This finding is consistent with 
what was reported in a study in Canada describ-
ing the process of insertion of seven pharma-
cists into primary care teams with the support 
of mentors that observed that time, adaptability 
and support are required for the effective inte-
gration of the pharmacist37. Participants reported 
that the mentor role was essential to ensure trust 
and skill development in both the care and inter-
personal aspects37. The integration process of the 
pharmacist to the team was facilitated by the sup-
port of the local manager and other actors, who 
acknowledged the advances in the structuring of 
the pharmacy and the training of the team by be-
coming allies in the implementation of interven-
tions. Although there was no mentor during the 
process, the pharmacist benefit from the experi-
ence of other pharmacists who worked in other 
spheres of municipal administration. The most 
relevant difficulties were lack of time due to the 
accumulation of activities and the lack of knowl-
edge of the pharmacist’s role due to the fact that 
there had never been one working in the unit.
The pharmacist’s interventions with pre-
scribers for changes to the prescribing standard 
prior to the disclosure of an internal memoran-
dum signed by the unit manager were ignored by 
prescribers. This occurred because they did not 
believe in the approval of the manager or in the 
legitimacy of the pharmacist’s role in issues ex-
ceeding the logistics aspect of the medicine. De-
spite the negative reaction, the maintenance of 
face-to-face interventions and the identification 
of the physicians who better accepted recruit-
ment interventions as multiplier agents allowed, 
with the support of the manager, the establish-
ment of a working relationship that went from 
respectful to harmonious and proactive over 
time, expanding the role of the pharmacist in 
clinical issues. 
Among the merits of the study is the fact that 
it describes several actions of the pharmacist in a 
primary care unit in a way that can guide the ac-
tion of professionals who are starting their activ-
ities. In addition, this is a real experience, which 
required time and coordination with other health 
professionals in order to achieve results, without 
the pharmacist being dedicated only to the assis-
tance activities. The main limitations are the de-
scriptive character of the study and the fact that it 
was performed in only one health unit (especially 
being a health service in which important chang-
es occurred, such as the implementation of ESF 
teams. These could interfere with the acceptance 
by the team since these professionals are already 
better accustomed to multidisciplinary work).
Conclusions
Despite the initial barriers, the integration of 
the pharmacist to the multiprofessional team al-
lowed him to play an important role in reducing 
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problems related to medicines and improving the 
quality of medical prescriptions. The presence of 
the pharmacist in the unit to carry out the inter-
ventions was of fundamental importance for the 
achievement of positive results.
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